HIV market to exceed $32 bn across 7MM in 2033, forecasts GlobalData

Read more

Coliform bacteria and E. coli in pharma water systems: A hidden threat to product integrity

Read more

Pharma CRDMO revenue forecasts 13-15 per cent growth amid supply-chain derisking

Read more

Enterprise Risk Management (ERM): A critical imperative for India’s pharma sector

Read more

We are well-aligned to capitalise on the CDMO opportunity

Read more

Lupin gains USFDA nod for Raltegravir Tablets USP, 600 mg

Read more

AstraZeneca’s Trastuzumab deruxtecan therapy receives CDSCO nod to manage HER2- low & ultra-low breast cancer in India

Read more

FABA, IIL, and ABF launch finishing school programme in Hyderabad

Read more

Sun Pharma launches corporate brand campaign in India

Read more

Supply chain leadership: Stepping into the spotlight

Read more